IP Library Assignment 075325/0017
Patent Assignment
Reel/Frame 075325/0017

Assignment of Assignor's Interest

Recorded: 2026-04-01 Pages: 31
Assignor
GEISTLICH PHARMA AG
Executed: 2026-03-10
Assignee
PERSEVERE THERAPEUTICS INC.
851 DUPORTAIL ROAD, 2ND FLOOR, CHESTERBROOK, PENNSYLVANIA, 19087
Covered Properties (15)
Oxathiazine Derivatives as Antibacterial and Anticancer Agents
Patent: 9,241,943 →
Application: 14/409,352 →
Publication: US 2015/0182534
Processes for Preparing Oxathiazin-Like Compounds
Application: 15/535,266 →
Publication: US 2018/0370932
Processes for Preparing Oxathiazin-Like Compounds
Application: 16/538,344 →
Publication: US 2019/0389819
Processes for Preparing Oxathiazin-Like Compounds
Application: 17/150,359 →
Publication: US 2021/0163432
Processes for Preparing Oxathiazin-Like Compounds
Application: 18/151,569 →
Publication: US 2023/0159477
Processes for Preparing Oxathiazin-Like Compounds
Application: 18/656,052 →
Publication: US 2024/0368097
Oxathiazine Derivatives as Antibacterial and Anticancer Agents
Patent: 9,624,187 →
Application: 14/958,225 →
Publication: US 2016/0159759
Oxathiazine Derivatives as Antibacterial and Anticancer Agents
Patent: 9,844,555 →
Application: 15/472,550 →
Publication: US 2017/0196876
Method of Treating Triple Negative Breast Cancer
Application: 16/085,294 →
Publication: US 2019/0091233
Process for Preparing Oxathiazin-Like Compounds
Application: 16/091,596 →
Publication: US 2019/0084950
Oxathiazin Compounds for Inhibiting Gapdh
Application: 17/612,950 →
Publication: US 2022/0313702
Oxathiazin_Dioxide for Treating, Preventing, Inhibiting or Reducing Cytokine Release
Application: 17/612,957 →
Publication: US 2022/0323423
Combination Therapy for Treating Cancers
Application: 18/995,420 →
Publication: US 2026/0021106
Combination Therapy for Treating Cancers
Application: 18/995,433 →
Publication: US 2026/0027126
Methods and Compositions for Oral Pharmaceutical Therapy
Patent: 9,028,866 →
Application: 13/701,372 →
Publication: US 2013/0089606
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 17, 2013
From: PFIRRMANN, ROLF W.; GEISTLICH, PETER
To: GEISTLICH PHARMA AG
Reel/Frame 029651/0655 →
Assignment of Assignor's Interest Apr 29, 2015
From: PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 035526/0934 →
Assignment of Assignor's Interest Dec 31, 2015
From: PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 037388/0645 →
Assignment of Assignor's Interest Jun 13, 2017
From: PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 042685/0819 →
Assignment of Assignor's Interest Jan 8, 2019
From: PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 047927/0435 →
Assignment of Assignor's Interest Apr 7, 2020
From: REDMOND, H. PAUL; PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 052332/0328 →
Assignment of Assignor's Interest Feb 19, 2021
From: MOEHLER, HANNS; MUELLER, THOMAS
To: GEISTLICH PHARMA AG
Reel/Frame 055335/0339 →
Assignment of Assignor's Interest Dec 7, 2021
From: MOEHLER, HANNS; COSTIN, JAMES C.; MUELLER, THOMAS
To: GEISTLICH PHARMA AG
Reel/Frame 058323/0188 →
Assignment of Assignor's Interest Dec 7, 2021
From: COSTIN, JAMES C.; MOEHLER, HANNS; MUELLER, THOMAS
To: GEISTLICH PHARMA AG
Reel/Frame 058323/0364 →
Assignment of Assignor's Interest Feb 8, 2022
From: PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 058930/0129 →
Assignment of Assignor's Interest Feb 8, 2022
From: PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 058930/0049 →
Assignment of Assignor's Interest Feb 9, 2022
From: PFIRRMANN, ROLF W.
To: GEISTLICH PHARMA AG
Reel/Frame 058938/0250 →
Assignment of Assignor's Interest Jan 9, 2023
From: PFIRRMANN, ROLF W.; MOEHLER, HANNS; MUELLER, THOMAS
To: GEISTLICH PHARMA AG
Reel/Frame 062313/0139 →
Assignment of Assignor's Interest May 9, 2024
From: PFIRRMANN, ROLF W.; MOEHLER, HANNS; MUELLER, THOMAS
To: GEISTLICH PHARMA AG
Reel/Frame 067359/0274 →
Assignment of Assignor's Interest Feb 21, 2025
From: COSTIN, JAMES C.; MOEHLER, HANNS
To: GEISTLICH PHARMA AG
Reel/Frame 070286/0862 →
Assignment of Assignor's Interest Feb 21, 2025
From: COSTIN, JAMES C.; MOEHLER, HANNS
To: GEISTLICH PHARMA AG
Reel/Frame 070286/0962 →